Tackling COVID-19
As we stay apart, pharmaceutical companies are coming together to fight against COVID-19
LEARN MOREIntellectual Property
Europe’s framework of incentives and rewards for discovering and developing new treatments deliver access to today’s medicines and investment into tomorrow’s cures for patients who need them.
LEARN MORE
Help us make rare disease even rarer
Only 8 OMP medicines existed in 2000, before the EU Regulation came in to force, compared to 184 today.
LEARN MORE
Relationships and Code
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals
LEARN MORE
Latest Updates
VIEW ALL-
Statements & press releases 27.01.21
EFPIA-Vaccines Europe statement on COVID-19 vaccines distribution
Scientists and experts are working day and night to address these challenges, increasing the capacity of manufacturing facilities and fine-tuning processes....
Read Article -
Blog articles 21.01.21
Podcast: Has COVID-19 transformed telemedicine forever?
Welcome to 19 Conversations
Read Article -
Blog articles 20.01.21
COVID-19: A data challenge and a catalyst for new insights (Guest blog)
The healthcare ecosystem is demonstrating its ability to share data to uncover new insights for the benefit of all during the pandemic but there is more...
Read Article -
External Events 09.03.21
Immunology Virtual Partnering
Autoimmune and Inflammatory Disease: During four days of face-to-face online meetings, leading researchers, top biotechs and biopharmaceutical companies...
View Event -
External Events 15.03.21
DIA Europe 2021
Dedicated to Advancing Healthcare Priorities
View Event -
External Events 15.04.21
Innovation for Health
On 15-16 April 2021, the 8th edition of Innovation for Health takes place as a hybrid edition.
View Event
Featured Articles
